366 related articles for article (PubMed ID: 19564750)
1. Kasabach-merritt phenomenon: case series and retrospective review of the mayo clinic experience.
Rodriguez V; Lee A; Witman PM; Anderson PA
J Pediatr Hematol Oncol; 2009 Jul; 31(7):522-6. PubMed ID: 19564750
[TBL] [Abstract][Full Text] [Related]
2. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment.
Hermans DJ; van Beynum IM; van der Vijver RJ; Kool LJ; de Blaauw I; van der Vleuten CJ
J Pediatr Hematol Oncol; 2011 May; 33(4):e171-3. PubMed ID: 21516018
[TBL] [Abstract][Full Text] [Related]
3. Vincristine-ticlopidine-aspirin: an effective therapy in children with Kasabach-Merritt phenomenon associated with vascular tumors.
Fernandez-Pineda I; Lopez-Gutierrez JC; Ramirez G; Marquez C
Pediatr Hematol Oncol; 2010 Nov; 27(8):641-5. PubMed ID: 20863161
[TBL] [Abstract][Full Text] [Related]
4. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon.
Gruman A; Liang MG; Mulliken JB; Fishman SJ; Burrows PE; Kozakewich HP; Blei F; Frieden IJ
J Am Acad Dermatol; 2005 Apr; 52(4):616-22. PubMed ID: 15793511
[TBL] [Abstract][Full Text] [Related]
5. Successful management of a retroperitoneal kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using alpha-interferon.
Harper L; Michel JL; Enjolras O; Raynaud-Mounet N; Rivière JP; Heigele T; De Napoli-Cocci S
Eur J Pediatr Surg; 2006 Oct; 16(5):369-72. PubMed ID: 17160787
[TBL] [Abstract][Full Text] [Related]
6. Residual lesions after Kasabach-Merritt phenomenon in 41 patients.
Enjolras O; Mulliken JB; Wassef M; Frieden IJ; Rieu PN; Burrows PE; Salhi A; Léauté-Labreze C; Kozakewich HP
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):225-35. PubMed ID: 10642677
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
Wang H; Guo X; Duan Y; Zheng B; Gao Y
Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
[TBL] [Abstract][Full Text] [Related]
8. [Kasabach-Merritt syndrome on a congenital tufted angioma].
Enjolras O; Wassef M; Dosquet C; Drouet L; Fortier G; Josset P; Merland JJ; Escande JP
Ann Dermatol Venereol; 1998 Apr; 125(4):257-60. PubMed ID: 9747263
[TBL] [Abstract][Full Text] [Related]
9. Medical management of tumors associated with Kasabach-Merritt phenomenon: an expert survey.
Tlougan BE; Lee MT; Drolet BA; Frieden IJ; Adams DM; Garzon MC
J Pediatr Hematol Oncol; 2013 Nov; 35(8):618-22. PubMed ID: 23774156
[TBL] [Abstract][Full Text] [Related]
10. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
Chiu YE; Drolet BA; Blei F; Carcao M; Fangusaro J; Kelly ME; Krol A; Lofgren S; Mancini AJ; Metry DW; Recht M; Silverman RA; Tom WL; Pope E
Pediatr Blood Cancer; 2012 Nov; 59(5):934-8. PubMed ID: 22648868
[TBL] [Abstract][Full Text] [Related]
11. Kaposiform hemangioendothelioma arising in the deltoid muscle without the Kasabach-Merritt phenomenon.
Tamai N; Hashii Y; Osuga K; Chihara T; Morii E; Aozasa K; Yoshikawa H
Skeletal Radiol; 2010 Oct; 39(10):1043-6. PubMed ID: 20309545
[TBL] [Abstract][Full Text] [Related]
12. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon.
Mariani LG; Schmitt IR; Garcia CD; Kiszewski AE
Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627
[No Abstract] [Full Text] [Related]
13. Kasabach-Merritt syndrome: a case review.
Szlachetka DM
Neonatal Netw; 1998 Feb; 17(1):7-15. PubMed ID: 9526357
[TBL] [Abstract][Full Text] [Related]
14. Successful management of Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using vincristine and ticlopidine.
López V; Martí N; Pereda C; Martín JM; Ramón D; Mayordomo E; Jordá E
Pediatr Dermatol; 2009; 26(3):365-6. PubMed ID: 19706115
[TBL] [Abstract][Full Text] [Related]
15. Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine.
Haisley-Royster C; Enjolras O; Frieden IJ; Garzon M; Lee M; Oranje A; de Laat PC; Madern GC; Gonzalez F; Frangoul H; Le Moine P; Prose NS; Adams DM
J Pediatr Hematol Oncol; 2002; 24(6):459-62. PubMed ID: 12218593
[TBL] [Abstract][Full Text] [Related]
16. Spindle cell (Kaposiform) hemangioendothelioma with Kasabach-Merritt syndrome in an infant: successful treatment with alpha-2A interferon.
Deb G; Jenkner A; De Sio L; Boldrini R; Bosman C; Standoli N; Donfrancesco A
Med Pediatr Oncol; 1997 May; 28(5):358-61. PubMed ID: 9121401
[TBL] [Abstract][Full Text] [Related]
17. Kasabach-Merritt Phenomenon: Classic Presentation and Management Options.
Mahajan P; Margolin J; Iacobas I
Clin Med Insights Blood Disord; 2017; 10():1179545X17699849. PubMed ID: 28579853
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.
Fernandez-Pineda I; Lopez-Gutierrez JC; Chocarro G; Bernabeu-Wittel J; Ramirez-Villar GL
Pediatr Blood Cancer; 2013 Sep; 60(9):1478-81. PubMed ID: 23609996
[TBL] [Abstract][Full Text] [Related]
19. Kaposiform hemangioendothelioma (with Kasabach Merritt syndrome) of the head and neck: case report and review of the literature.
Mukerji SS; Osborn AJ; Roberts J; Valdez TA
Int J Pediatr Otorhinolaryngol; 2009 Oct; 73(10):1474-6. PubMed ID: 19643504
[TBL] [Abstract][Full Text] [Related]
20. Hemangioma-thrombocytopenia syndrome; a disseminated intravascular coagulopathy.
Lang PG; Dubin HV
Arch Dermatol; 1975 Jan; 111(1):105-7. PubMed ID: 1168040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
